Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Lymphangioleiomyomatosis Clinical Trials

3 recruiting trials for Lymphangioleiomyomatosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
RECRUITINGNCT00001465

Study of the Disease Process of Lymphangioleiomyomatosis

Pulmonary lymphangioleiomyomatosis (LAM) is a destructive lung disease typically affecting women of childbearing age. Currently, there is no effective therapy for the disease and...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 20001 location
RECRUITINGNCT05676099

TSC Biosample Repository and Natural History Database

The TSC Biosample Repository collects and stores samples of blood, DNA, and tissues that scientists can request to use in their research. The samples we collect are all linked to...

Sponsor: National Tuberous Sclerosis AssociationEnrolling: 500020 locations